Robert van Nostrand
Vorsitzender bei YIELD10 BIOSCIENCE, INC.
Vermögen: 726 371 $ am 30.04.2024
Aktive Positionen von Robert van Nostrand
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
INTRA-CELLULAR THERAPIES, INC. | Direktor/Vorstandsmitglied | 08.01.2014 | - |
Independent Dir/Board Member | 08.01.2014 | - | |
YIELD10 BIOSCIENCE, INC. | Independent Dir/Board Member | 01.10.2006 | - |
Vorsitzender | 08.11.2011 | - | |
Direktor/Vorstandsmitglied | 01.10.2006 | 26.12.2013 | |
SELLAS LIFE SCIENCES GROUP, INC. | Direktor/Vorstandsmitglied | 29.12.2017 | - |
Independent Dir/Board Member | 29.12.2017 | - | |
LikeMinds, Inc. (Massachusetts)
LikeMinds, Inc. (Massachusetts) Personnel ServicesCommercial Services LikeMinds, Inc. intends to make brain imaging part of the standard suite of healthcare diagnostic tests and technologies. The company was founded in 2018 and is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | - | - |
Sellas Life Sciences Group Ltd.
Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland. | Direktor/Vorstandsmitglied | 29.12.2017 | - |
ITI, Inc. (New York) | Direktor/Vorstandsmitglied | 01.01.2014 | - |
Brany LLC
Brany LLC Miscellaneous Commercial ServicesCommercial Services Brany LLC is a private company that has been providing support to sponsors, institutions, and investigators since 1998. The company is based in Lake Success, NY. The company offers IRB and clinical trial solutions that can fill in gaps or enhance existing processes. | Direktor/Vorstandsmitglied | 01.01.2011 | - |
Association of Biofinance Officers | Corporate Officer/Principal | - | - |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | Direktor/Vorstandsmitglied | 20.07.2012 | - |
Treasurer | - | - | |
Vorsitzender | - | 20.07.2012 |
Karriereverlauf von Robert van Nostrand
Ehemalige bekannte Positionen von Robert van Nostrand
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - | - |
░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░ ░░░░ ░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░ | - | - |
Ausbildung von Robert van Nostrand
Long Island University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 22 |
Bermuda | 2 |
Operativ
Director/Board Member | 15 |
Independent Dir/Board Member | 5 |
Director of Finance/CFO | 4 |
Sektoral
Health Technology | 10 |
Commercial Services | 6 |
Process Industries | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
INTRA-CELLULAR THERAPIES, INC. | Health Technology |
YIELD10 BIOSCIENCE, INC. | Process Industries |
SELLAS LIFE SCIENCES GROUP, INC. | Health Technology |
Private Unternehmen | 18 |
---|---|
OSI Pharmaceuticals, Inc.
OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Achillion Pharmaceuticals, Inc.
Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
Apex Bioventures Acquisition Corp.
Apex Bioventures Acquisition Corp. Financial ConglomeratesFinance The Company is a blank check company. It is formed to acquire one or more domestic or foreign operating business in the healthcare industry through merger, capital stock exchange, asset acquisition or other similar business combination. The Company is in the development stage. On February 5, 2008, the Company entered into an Agreement and Plan of Merger with Dynogen Pharmaceuticals, Inc and its acting representatives. | Finance |
Applied Genetics, Inc. Dermatics
Applied Genetics, Inc. Dermatics Pharmaceuticals: MajorHealth Technology Applied Genetics, Inc. Dermatics develops and markets pharmaceutical drugs, skincare ingredients and prestige products. It develops array of cosmetic ingredients to use in skin care products. The company has focused on ingredients for skin protection from environmental damage. The firm also has a topical pharmaceutical product in clinical testing called Dimericine for cancer-prone skin. Applied Genetics was founded by Daniel B Yarosh and Karen Yarosh in May 1985 and is headquartered in Freeport, NY. | Health Technology |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | Commercial Services |
Association of Biofinance Officers | |
Apex Bioventures LLC | |
Aureon Biosciences, Inc.
Aureon Biosciences, Inc. BiotechnologyHealth Technology Aureon Biosciences, Inc. designs and develops prognostic tests. The company’s prognostic tests include Prostate Px, which assists physicians as they counsel patients on the range of possible treatment options, as well as the patient’s probability of disease recurrence, disease progression and Post-Op Px, a prognostic test to provide patients and their physicians with information about treatment options. The company was founded by Robert H. Singer, Charles M. Cohen, Jonathan Edelson, Olivier Saidi and Carlos Cordón-Cardó in 2001 and is headquartered in Yonkers, NY. | Health Technology |
Brany LLC
Brany LLC Miscellaneous Commercial ServicesCommercial Services Brany LLC is a private company that has been providing support to sponsors, institutions, and investigators since 1998. The company is based in Lake Success, NY. The company offers IRB and clinical trial solutions that can fill in gaps or enhance existing processes. | Commercial Services |
ITI, Inc. (New York) | |
Farmingdale College Foundation | |
Enumeral Biomedical Holdings, Inc.
Enumeral Biomedical Holdings, Inc. BiotechnologyHealth Technology Enumeral Biomedical Holdings, Inc. is a biopharmaceutical company, which engages in the business of discovering and developing novel antibody immunotherapies for the treatment of cancer and other diseases. It also focuses on the development of a pipeline of next generation monoclonal antibody drugs targeting established and novel immuno-modulatory receptors. The company was founded by Barry C. Buckland, John J. Rydzewski, and Arthur H. Tinkelenberg on December 11, 2009 and is headquartered in Arlington, MA. | Health Technology |
Touche Ross & Co. | Commercial Services |
SELLAS Life Sciences Group, Inc. /Old/
SELLAS Life Sciences Group, Inc. /Old/ BiotechnologyHealth Technology SELLAS Life Sciences Group, Inc. /Old/ is based in New York, NY. SELLAS Life Sciences Group, Inc. is a clinical-stage biopharmaceutical company. | Health Technology |
Sellas Life Sciences Group Ltd.
Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland. | Health Technology |
Enumeral Biomedical Corp.
Enumeral Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Enumeral Biomedical Corp. develops monoclonal antibodies for diagnosis and treatment of infectious, autoimmune and inflammatory diseases. Its proprietary micro engraving technology creates spatially-registered, high-density bio-chip microarrays of the secreted products of single human cells derived from patient samples to provide rapid and simultaneous analysis of antibody affinity and specificity as well as cytokine profiles and T-cell functionality. The company was founded in 2009 by J. Christopher Love, Emanuele Ostuni and Barry Buckland and is headquartered in New York, NY. | Commercial Services |
LikeMinds, Inc. (Massachusetts)
LikeMinds, Inc. (Massachusetts) Personnel ServicesCommercial Services LikeMinds, Inc. intends to make brain imaging part of the standard suite of healthcare diagnostic tests and technologies. The company was founded in 2018 and is headquartered in Boston, MA. | Commercial Services |
Aureon Laboratories, Inc. |
- Börse
- Insiders
- Robert van Nostrand
- Erfahrung